Cynata Therapeutics Limited (CYP.AX) - Stock Prices, Stock Peers & Analysis

Home
CYP.AX

Company Name	Cynata Therapeutics Limited
Symbol	CYP.AX
Currency	AUD
Price	0.235
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	42,458,860
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	0.105 - 0.345
Industry	Biotechnology
Sector	Healthcare
CEO	Dr. Kilian Kelly
Website	https://www.cynata.com

An error occurred while fetching data.

About Cynata Therapeutics Limited

Cynata Therapeutics Limited, together with its subsidiaries, develops and commercializes a proprietary mesenchymal stem cell technology under the Cymerus brand for human therapeutic use in Australia. The company's lead therapeutic product candidate is CYP-001, which has completed Phase I clinical trial for the treatment of graft versus host disease. It